Investigating mechanisms underlying the development of paralysis symptom in a model of MS

Shruti Gupta1, Sreejita Arnab1, Noah Silver-Beck2

  • 1Department of Anatomy and Cell Biology, The George Washington University, Ross Hall, Washington D.C. 20052, United States.

Brain Research Bulletin
|February 28, 2025
PubMed

Insights

Multiple sclerosis (MS) pain is comparable in mice with or without paralysis. However, paralysis involves increased immune cell activation, demyelination, and CXCL13 in the spinal cord.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathophysiology

Background:

  • Multiple sclerosis (MS) is a neurodegenerative autoimmune disorder impacting many patients with pain and paralysis.
  • Research has focused on paralysis in experimental autoimmune encephalomyelitis (EAE), a rodent model for MS, with less attention to MS-associated pain.
  • The underlying causes for the varying severity of pain and motor symptoms in MS remain understudied.

Purpose of the Study:

  • This study aimed to dissect the pathophysiology of MS symptoms in a non-PTX EAE model.
  • The research compared mice experiencing mechanical hypersensitivity (pain) with and without paralysis.

Main Methods:

  • Utilized the non-PTX EAE rodent model to study MS pathophysiology.
  • Assessed mechanical hypersensitivity, paralysis, immune cell activation and infiltration, demyelination, and CXCL13 protein expression in the spinal cord.

Main Results:

  • Mechanical hypersensitivity was comparable between EAE mice with and without paralysis, irrespective of sex.
  • Mice with both mechanical hypersensitivity and paralysis showed significantly increased immune cell activation and infiltration, demyelination, and CXCL13 protein levels in the spinal cord compared to those with only hypersensitivity.

Conclusions:

  • Pain-like phenotypes in EAE are not solely dependent on the presence of paralysis.
  • Paralysis in EAE is associated with distinct pathological changes in the spinal cord, including heightened neuroinflammation and demyelination, potentially mediated by CXCL13.